Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Filings indexed 1,697 across all filing types
Latest filing 2019-04-09 Regulatory Filings
Country TW Taiwan
Listing TW 4119

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
108年3月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 旭富 for the period of March 2019 (民國108年03月). It contains monthly and cumulative revenue figures, percentage changes compared to the previous year, and explanations for revenue changes. The document is short (811 characters) and appears to be a periodic financial data disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more of a regulatory disclosure of revenue figures, which fits best under Regulatory Filings (RNS) as a general regulatory announcement of financial data without full report content.
2019-04-09 Chinese
107年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table summarizing key financial ratios and metrics for a company named 旭富 over three fiscal years (105年度, 106年度, 107年度). The data includes leverage ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is relatively short (1015 characters) and appears to be a summary or analysis of financial data rather than a full financial report. There is no indication that this is a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It also does not contain any narrative management discussion or detailed financial statements. Given the concise nature and focus on key financial metrics over multiple years, this document best fits the category of a Fund Information / Factsheet (FS), which typically provides brief summaries of key financial facts and figures.
2019-03-27 Chinese
公告本公司於3月21日受犇亞證券邀請說明營運概況
Investor Presentation Classification · 90% confidence The document is a short announcement (619 characters) about a scheduled investor presentation (法人說明會) on March 21, 2019, where the company will explain its operational overview. It provides details such as date, time, location, and a brief description of the event. There is no actual financial data or detailed report content included. The document serves as a notice for an upcoming investor presentation rather than the presentation itself or a financial report. Therefore, it fits the category of Investor Presentation (IP) announcement.
2019-03-20 Chinese
108年03月法人說明會簡報 — 411920190319E001.pdf
Regulatory Filings
2019-03-20 Chinese
108年03月法人說明會簡報 — 411920190319M001.pdf
Annual Report Classification · 95% confidence The document contains detailed financial data for years 2017 and 2018, including sales, gross profit, operating expenses, and net profit after tax. It also provides extensive business and product information, market segmentation, and product profiles with applications and regulatory certifications. The length is 9164 characters, which is substantial and contains actual financial statements and analysis. There is no indication that this is merely an announcement or a presentation; rather, it appears to be a comprehensive report covering company activity and financial performance for a full fiscal year. Therefore, this document fits the definition of an Annual Report (10-K). Q1 2019
2019-03-20 Chinese
108年03月法人說明會簡報 — 411920190308E001.pdf
Regulatory Filings
2019-03-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.